SCYXMICRO

SCYNEXIS, Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$0.96
$0.00(-2.51%)
52W$0.56
$1.31
Updated May 7, 12:00 AM
RSI51
RS Rating86/99
Beta0.78
Volatility78%
F-Score5/9
Mkt Cap$42M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

SCYNEXIS, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings growth of 333% provides fundamental context to the price action. Investors should exercise caution due to high volatility (78% annualized), which requires wider risk management.

Relative Strength
86
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.78
vs S&P 500
DEFENSIVE
52W Position
53%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.92
50 SMA > 100 SMA$0.81
100 SMA > 150 SMA$0.77
150 SMA > 200 SMA$0.80

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.01-5.39%BELOW
50 SMA$0.92+3.69%ABOVE
100 SMA$0.81+18.08%ABOVE
150 SMA$0.77+24.05%ABOVE
200 SMA$0.80+19.77%ABOVE

Price Performance

1D-2.5%
1W+2.9%
1M-0.2%
3M+27.5%
6M+60.9%
YTD+49.8%
1Y-0.4%
3Y-31.5%
52-Week Trading Range53% from low
$0.96
52W Low$0.56
52W High$1.31

Technical Indicators

RSI (14)NEUTRAL
51.3
305070
VCP ScoreCOOL
5/10
Base depth: 46.4%

Risk Profile

Beta
0.78
52W Vol
78%
ATR
$0.07
Max DD (1Y)
-51%

Volume Analysis

Today
131.4K
50D Avg
570.7K
Vol Ratio
0.23x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-1394%
$-0.11
Q2'25+53%
$-0.14
Q3'25-194%
$-0.17
Q4'25+333%
$0.28
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+55.02%
5 Years:
3 Years:+59.35%
TTM:+449.95%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+70.17%

Stock Price CAGR

10 Years:-31.06%
5 Years:-32.58%
3 Years:-31.51%
1 Year:-0.41%

Return on Equity

10Y Avg:-102.6%
5Y Avg:-51.8%
3Y Avg:42.1%
Last Year:-19.0%

Key Metrics

Market Cap$42M
Gross Margin
Net Margin-41.8%
Piotroski F-Score5/9

Frequently Asked Questions

Is SCYX in an uptrend right now?

SCYX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is SCYX overbought or oversold?

SCYX's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is SCYX outperforming the market?

SCYX has a Relative Strength (RS) Rating of 86 out of 99. Yes, SCYX is a market leader, outperforming 86% of all stocks over the past 12 months.

Where is SCYX in its 52-week range?

SCYX is trading at $0.96, which is 73% of its 52-week high ($1.31) and 53% above its 52-week low ($0.56).

How volatile is SCYX?

SCYX has a Beta of 0.78 and 52-week volatility of 78%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.